Monday, June 15, 2026

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

South Korea Moves to Approve $350 Billion US Investment Plan as Tariff Pressure Mounts

South Korea is advancing a Special Bill for U.S. investment, targeting $350 billion, while facing legislative hurdles and U.S. pressure.

How the Ongoing Middle East Conflict is Impacting South Korea’s Medical Supply Chain

The Ministry of Health and Welfare discussed pharmaceutical supply stability amid Middle East conflict, ensuring proactive monitoring and response.

Tag: Jingle Ball

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.